HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Shi Selected Research

Annexin A1

7/2022Multiple Mild Stimulations Reduce Membrane Distribution of CX3CR1 Promoted by Annexin a1 in Microglia to Attenuate Excessive Dendritic Spine Pruning and Cognitive Deficits Caused by a Transient Ischemic Attack in Mice.
1/2022Electroacupuncture promotes microglial M2 polarization in ischemic stroke via annexin A1.
1/2019A novel cell-penetrating peptide protects against neuron apoptosis after cerebral ischemia by inhibiting the nuclear translocation of annexin A1.
1/2018S100A11 protects against neuronal cell apoptosis induced by cerebral ischemia via inhibiting the nuclear translocation of annexin A1.
1/2017Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Shi Research Topics

Disease

57Neoplasms (Cancer)
12/2022 - 12/2003
30Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2006
24Pain (Aches)
03/2022 - 02/2005
23Infections
04/2021 - 08/2005
17Inflammation (Inflammations)
10/2022 - 02/2007
17Stroke (Strokes)
01/2022 - 06/2004
16Acute Kidney Injury (Acute Renal Failure)
10/2022 - 02/2013
14Dementia (Dementias)
03/2022 - 06/2004
14Brain Ischemia (Cerebral Ischemia)
06/2021 - 01/2003
14Rheumatoid Arthritis
01/2021 - 10/2011
13Breast Neoplasms (Breast Cancer)
02/2021 - 02/2007
13Ischemia
10/2019 - 01/2005
12Lung Neoplasms (Lung Cancer)
01/2022 - 05/2008
11Hypoxia (Hypoxemia)
10/2022 - 02/2006
11Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2012
11Cognitive Dysfunction
01/2022 - 01/2008
10Ischemic Stroke
01/2022 - 07/2013
10Neuralgia (Stump Neuralgia)
01/2021 - 01/2003
9Starvation
01/2020 - 01/2013
8Hepatocellular Carcinoma (Hepatoma)
12/2022 - 08/2010
8Schizophrenia (Dementia Praecox)
01/2022 - 03/2015
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2013
8Neoplasm Metastasis (Metastasis)
01/2022 - 08/2013
8Hypertension (High Blood Pressure)
01/2021 - 06/2009
6Migraine Disorders (Migraine)
02/2022 - 08/2007
6Pneumonia (Pneumonitis)
01/2021 - 03/2010
6Kidney Diseases (Kidney Disease)
10/2019 - 11/2014
6Hyperalgesia
01/2017 - 02/2005
6Arthritis (Polyarthritis)
11/2015 - 02/2007
5Body Weight (Weight, Body)
07/2022 - 10/2007
5Necrosis
04/2022 - 05/2008
5Cardiotoxicity
04/2022 - 01/2017
5Fibrosis (Cirrhosis)
01/2022 - 10/2011
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 01/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 09/2006
5Infarction (Infarctions)
06/2021 - 07/2013
5COVID-19
01/2021 - 01/2020
5Sepsis (Septicemia)
01/2021 - 03/2010
5Type 2 Diabetes Mellitus (MODY)
08/2020 - 04/2014
5Facial Paralysis (Facial Palsy)
05/2019 - 10/2012
5Carcinogenesis
04/2019 - 05/2005
5Asthma (Bronchial Asthma)
03/2019 - 05/2004
5Urinary Bladder Neoplasms (Bladder Cancer)
07/2017 - 01/2014
5Tardive Dyskinesia
12/2016 - 10/2013
5Poisoning
01/2012 - 06/2006

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
07/2022 - 08/2005
31Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2008
19Therapeutic UsesIBA
07/2022 - 08/2007
18Pharmaceutical PreparationsIBA
04/2022 - 06/2006
16AntibodiesIBA
01/2018 - 04/2006
14Messenger RNA (mRNA)IBA
01/2022 - 01/2003
12MicroRNAs (MicroRNA)IBA
10/2022 - 01/2016
12Biological ProductsIBA
10/2022 - 01/2008
12Glucose (Dextrose)FDA LinkGeneric
02/2022 - 01/2005
10salicylhydroxamic acid (SHAM)IBA
01/2019 - 12/2006
8Insulin (Novolin)FDA Link
01/2022 - 01/2008
8VaccinesIBA
01/2021 - 03/2010
8EnzymesIBA
12/2020 - 05/2004
8Freund's AdjuvantIBA
05/2020 - 02/2005
7Phosphates (Orthophosphate)IBA
10/2022 - 03/2014
7Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 04/2016
7LipidsIBA
01/2022 - 02/2007
7AntigensIBA
01/2021 - 03/2010
7Insulin-Like Growth Factor Binding ProteinsIBA
01/2021 - 04/2014
7CreatinineIBA
01/2021 - 01/2013
7Analgesics (Analgesic Drugs)IBA
05/2020 - 06/2006
6Oxygen (Dioxygen)IBA
10/2022 - 01/2005
6Doxorubicin (Adriamycin)FDA LinkGeneric
07/2020 - 08/2014
6AutoantibodiesIBA
09/2018 - 10/2011
6CurcuminIBA
07/2017 - 02/2014
5Long Noncoding RNAIBA
12/2022 - 01/2019
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022 - 01/2018
5Annexin A1IBA
07/2022 - 01/2017
5Phosphotransferases (Kinase)IBA
01/2022 - 05/2011
5Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2011
5Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2015
5CytokinesIBA
04/2021 - 01/2016
5TicagrelorIBA
01/2021 - 01/2016
5Clopidogrel (Plavix)FDA Link
01/2021 - 01/2016
5Aluminum Oxide (Sapphire)IBA
01/2021 - 02/2013
5CalciumIBA
01/2021 - 08/2007
5Peptides (Polypeptides)IBA
05/2020 - 04/2009
5Immunoglobulin G (IgG)IBA
05/2020 - 01/2013
5Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2020 - 05/2015
5Indicators and Reagents (Reagents)IBA
01/2020 - 03/2013
5AnthracyclinesIBA
05/2019 - 04/2015
5TabletsIBA
12/2018 - 10/2006
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2022 - 05/2004

Therapy/Procedure

49Therapeutics
04/2022 - 05/2007
20Acupuncture Points (Acupuncture Point)
02/2022 - 01/2006
19Electroacupuncture
01/2022 - 01/2003
18Drug Therapy (Chemotherapy)
01/2022 - 12/2003
14Percutaneous Collagen Induction
02/2022 - 03/2004
9Acupuncture Therapy
02/2022 - 10/2013
7Activities of Daily Living (ADL)
01/2021 - 01/2008
6Moxibustion
02/2022 - 09/2014
6Length of Stay
01/2022 - 01/2015
6Aftercare (After-Treatment)
09/2020 - 08/2008
6Immunotherapy
01/2020 - 06/2016
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2008